Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Epigenetic signatures in stem cells and cancer stem cells.

Hernandez-Vargas H, Sincic N, Ouzounova M, Herceg Z.

Epigenomics. 2009 Dec;1(2):261-80. doi: 10.2217/epi.09.19. Review.

PMID:
22122702
2.

Histone acetylation and chromatin signature in stem cell identity and cancer.

Shukla V, Vaissière T, Herceg Z.

Mutat Res. 2008 Jan 1;637(1-2):1-15. Review.

PMID:
17850830
3.

Epigenetic regulation of telomere chromatin integrity in pluripotent embryonic stem cells.

Wong LH.

Epigenomics. 2010 Oct;2(5):639-55. doi: 10.2217/epi.10.49. Review.

PMID:
22122049
4.

Epigenetic modifications of stem cells: a paradigm for the control of cardiac progenitor cells.

Zhou Y, Kim J, Yuan X, Braun T.

Circ Res. 2011 Oct 14;109(9):1067-81. doi: 10.1161/CIRCRESAHA.111.243709. Review.

5.

Molecular basis of pluripotency.

Chen L, Daley GQ.

Hum Mol Genet. 2008 Apr 15;17(R1):R23-7. doi: 10.1093/hmg/ddn050. Review.

PMID:
18632692
6.

Epigenetic regulatory mechanisms during preimplantation development.

Corry GN, Tanasijevic B, Barry ER, Krueger W, Rasmussen TP.

Birth Defects Res C Embryo Today. 2009 Dec;87(4):297-313. doi: 10.1002/bdrc.20165. Review.

PMID:
19960551
7.

Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation.

Atkinson S, Armstrong L.

Cell Tissue Res. 2008 Jan;331(1):23-9. Review.

PMID:
18004593
8.

miR-302b maintains "stemness" of human embryonal carcinoma cells by post-transcriptional regulation of Cyclin D2 expression.

Lee NS, Kim JS, Cho WJ, Lee MR, Steiner R, Gompers A, Ling D, Zhang J, Strom P, Behlke M, Moon SH, Salvaterra PM, Jove R, Kim KS.

Biochem Biophys Res Commun. 2008 Dec 12;377(2):434-40. doi: 10.1016/j.bbrc.2008.09.159.

PMID:
18930031
9.

[The alchemy--epigenetic regulation of pluripotency].

Bem J, Grabowska I.

Postepy Biochem. 2013;59(2):144-56. Review. Polish.

PMID:
24044279
10.

Epigenetic codes in stem cells and cancer stem cells.

Yamada Y, Watanabe A.

Adv Genet. 2010;70:177-99. doi: 10.1016/B978-0-12-380866-0.60007-1. Review.

PMID:
20920749
11.

Epigenetic control of embryonic stem cell fate.

Christophersen NS, Helin K.

J Exp Med. 2010 Oct 25;207(11):2287-95. doi: 10.1084/jem.20101438. Review.

12.

The epigenetic basis for embryonic stem cell pluripotency.

Szutorisz H, Dillon N.

Bioessays. 2005 Dec;27(12):1286-93.

PMID:
16299767
13.

[Epigenetic regulation involved in fate specification of neural cells].

Sanosaka T, Tsujimura K, Nakashima K.

Tanpakushitsu Kakusan Koso. 2008 Mar;53(4 Suppl):331-7. Review. Japanese. No abstract available.

PMID:
21089300
14.
15.

Epigenetic plasticity of hematopoietic cells.

Bonifer C.

Cell Cycle. 2005 Feb;4(2):211-4.

PMID:
15655346
16.

Chromatin plasticity in pluripotent cells.

Melcer S, Meshorer E.

Essays Biochem. 2010 Sep 20;48(1):245-62. doi: 10.1042/bse0480245. Review.

PMID:
20822497
17.

Transcriptional regulation by DNA methylation.

Poetsch AR, Plass C.

Cancer Treat Rev. 2011;37 Suppl 1:S8-12. doi: 10.1016/j.ctrv.2011.04.010. Review.

PMID:
21601364
18.

Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.

Chang G, Miao YL, Zhang Y, Liu S, Kou Z, Ding J, Chen DY, Sun QY, Gao S.

PLoS One. 2010 Apr 26;5(4):e10320. doi: 10.1371/journal.pone.0010320.

19.

Methylation in embryonic stem cells in vitro.

Nishino K, Ohgane J, Suzuki M, Hattori N, Shiota K.

Methods Mol Biol. 2006;329:421-45.

PMID:
16846008
20.

The epigenome in pluripotency and differentiation.

Thiagarajan RD, Morey R, Laurent LC.

Epigenomics. 2014 Feb;6(1):121-37. doi: 10.2217/epi.13.80. Review.

PMID:
24579950
Items per page

Supplemental Content

Support Center